Evolving role of pharmaceutical physicians in medical evidence and education

References

• PharmaForumMedical Affairs – the heart of a data-driven, patient-centric pharma2017 Available from: https://pharmaphorum.com/views-and-analysis/medical-affairs-heart-data-driven-patient-centric-pharma/Accessed April 28, 2018
   Google Scholar
• JainSBridging the Gap Between R&D and commercialization in pharmaceutical industry: role of medical affairs and medical communicationsInt J Biomed Sci2017334449
   Google Scholar
• GromTMedical affairs: beyond the scienceShowcase feature2013 Available from: http://www.pharmavoice.com/article/medical-affairs-beyond-the-science/Accessed April 24, 2018
   Google Scholar
• RollinsBLPerriMPharmaceutical MarketingBurlingtonJones & Bartlett Learning2014
   Google Scholar
• PlantevinLSchlegelCGordianMReinventing the Role of Medical Affairs2017 Available from: http://www.bain.com/publications/articles/reinventing-the-role-of-medical-affairs.aspxAccessed April 24, 2018
   Google Scholar
• EversMFlemingEGhatakAPharma Medical Affairs: 2020 and beyondNew YorkMcKinsey & Company2014
   Google Scholar
• PatwardhanARPhysicians-pharmaceutical sales representatives interactions and conflict of interest: challenges and solutionsInquiry201653004695801666759727637269
   PubMed Web of Science ®Google Scholar
• van BisenTWeisbrodJBrookshireMCoffmanJPasternakAFront Line of Healthcare Report 2017: Why involving doctors can help improve US healthcare2017 Available from: http://www.bain.com/publications/articles/front-line-of-healthcare-report-2017.aspxAccessed April 24, 2018
   Google Scholar
• NatanekRSchlegelCRetterathMEliadesGHow to Make Your Drug Launch a Success Available from: https://www.bain.com/insights/how-to-make-your-drug-launch-a-success/Accessed April 26, 2018
   Google Scholar
• FirstWorldThe Future of Medical Affairs2016 Available from: http://www.fwreports.com/dossier/the-future-of-medical-affairs/#.W8UdbGgzY2wAccessed October 18, 2018
   Google Scholar
• RutherfordPSmithNJMedical Science Liaisons: A Key to Driving Patient Access to New TherapiesQuintilesIMS 2016 Available from: https://www.iqvia.com/-/media/library/white-papers/medical-science-liaisons.pdfAccessed April 26, 2018
   Google Scholar
• Medical Science Liaison SocietyWhat Is a Medical Science Liaison?2018 Available from: http://www.themsls.org/what-is-an-msl/Accessed April 26, 2018
   Google Scholar
• KausaISA day in the life of a pharmaceutical physician2007 Available from: http://careers.bmj.com/careers/advice/view-article.html?id=2461Accessed April 24, 2018
   Google Scholar
• International Federation of Pharmaceutical Manufacturers & AssociationsIFPMA Code of PracticeGeneva, SwitzerlandInternational Federation of Pharmaceutical Manufacturers & Associations2012 Available from: https://www.ifpma.org/subtopics/code-of-practice-2/Accessed April 26, 2018
   Google Scholar
• PressonJAdvisory Board Functions Expanding in Pharma Industry2018 Available from: https://www.cuttingedgeinfo.com/2013/advisory-board-functions-expanding-pharma-industry/Accessed April 24, 2018
   Google Scholar
• EvensRDrug and Biological Development: From Molecule to Product and BeyondVerlagSpringer2007240274
   Google Scholar
• Best PracticesNew Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector Available from: https://www.prnewswire.com/news-releases/new-study-presents-insights-to-advisory-board-effectiveness-in-the-pharmaceutical-sector-300076091.htmlAccessed April 24, 2018
   Google Scholar
• American Express Open Access10 Steps to forming an effective advisory board2011 Available from: https://www.americanexpress.com/us/small-business/openforum/articles/10-steps-to-forming-an-effective-advisory-board-1/Accessed April 24, 2018
   Google Scholar
• BalasubramanianGMorampudiSChhabraPGowdaAZomorodiBArun GowdaBZAn overview of Compassionate Use Programs in the European Union member statesIntractable Rare Dis Res20165424425427904819
   PubMedGoogle Scholar
• PatilSEarly access programs: benefits, challenges, and key considerations for successful implementationPerspect Clin Res2016714826955570
   PubMedGoogle Scholar
• YazdaniMBoggiFInitiating Early Access Programs: 5 Things to Consider2018 Available from: http://www.executiveinsight.ch/early_access_programsAccessed April 24, 2018
   Google Scholar
• BerroMBurnettBKFromellGJSupport for investigator-initiated clinical research involving investigational drugs or devices: the Clinical and Translational Science Award experienceAcad Med201186221722321169787
   PubMed Web of Science ®Google Scholar
• SuvarnaVInvestigator initiated trials (IITs)Perspect Clin Res20123411912123293757
   PubMedGoogle Scholar
• Cutting Edge InformationMedical Science Liaisons Aim to Support Investigator Initiated Trials2012 Available from: https://www.businesswire.com/news/home/20121016005277/en/Medical-Science-Liaisons-Aim-Support-Investigator-InitiatedAccessed April 24 2018
   Google Scholar
• SullivanGMGetting off the “gold standard”: randomized controlled trials and education researchJ Grad Med Educ20113328528922942950
   PubMedGoogle Scholar
• HaidichABMeta-analysis in medical researchHippokratia201014Suppl 1293721487488
   PubMed Web of Science ®Google Scholar
• ChanEWLiuKQChuiCSSingCWWongLYWongICAdverse drug reactions: examples of detection of rare events using databasesBr J Clin Pharmacol201580485586125060360
   PubMed Web of Science ®Google Scholar
• McKessonReal-World Evidence from Electronic Health Record Data2017 Available from: http://www.mckesson.com/blog/real-world-evidence-from-electronic-health-record-data/Accessed April 24, 2018
   Google Scholar
• GrudzinskasCAtkinsonJDesign of Clinical Development ProgramsArthurJAtkinsonJAbernethyDarrell RDanielsCharles EDedrickRobert LMarkeySanford PPrinciples of Clinical Pharmacology2nd ed2007501517
   Google Scholar
• DekovenMHazardEHGoldbergEPokrasSGot value? Determine it. Demonstrate it. Communicate it. Realise itJ Commerc Biotechnol2008144299306
   Google Scholar
• Canadian Agency for Drugs and Technologies in HealthWhat Does the Evidence Say?2018 Available from: https://www.cadth.ca/about-cadthAccessed April 24, 2018
   Google Scholar
• ISPORDirectory of Health Technology Assessment Organizations Worldwide2018 Available from: https://www.ispor.org/HTADirectory/Index.aspxAccessed April 26, 2018
   Google Scholar
• INHATAINAHTA Members List2018 Available from: http://www.inahta.org/members/members_list/Accessed April 24, 2018
   Google Scholar
• European Federation of Pharmaceutical Industries and AssociationsThe Use of Health Technology Assessments to Evaluate Medicines2005 Available from: https://www.efpia.eu/media/25170/the-use-of-health-technology-assessments-hta-to-evaluate-medicines-key-principles-2007.pdfAccessed April 24, 2018
   Google Scholar
• Ministry of Health SingaporeAbout Us2018 Available from: https://www.moh.gov.sg/content/dam/moh_web/ACE-HTA/about-us.html#who-we-areAccessed April 24, 2018
   Google Scholar
• ShiroiwaTFukudaTIkedaSTakuraTNew decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluationsHealth Policy2017121883684128687183
   PubMed Web of Science ®Google Scholar
• BarberJMSheehyKPUptake of new medicines in New Zealand: evidence of a waiting listN Z Med J201512814121020
   Google Scholar
• European Network for Health Technology AssessmentEUnetHTA and the HTA Network2018 Available from: https://www.eunethta.eu/about-eunethta/our-network/Accessed April 26, 2018
   Google Scholar
• BrockisEMarsdenGColeADevlinNA Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and ImplicationsOffice of Health Economics2016 https://www.ohe.org/publications/review-nice-methods-across-health-technology-assessment-programmes-differencesAccessed September 28, 2018
   Google Scholar
• Pichon-RiviereAAugustovskiFRubinsteinAMartíSGSullivanSDDrummondMFHealth technology assessment for resource allocation decisions: are key principles relevant for Latin America?Int J Technol Assess Health Care201026442142720942985
   PubMed Web of Science ®Google Scholar
• PMLiveNovo Nordisk’s Klaus Henning Jensen on trends in medical affairs2018 Available from: http://www.pmlive.com/pharma_thought_leadership/novo_nordisks_klaus_henning_jen-sen_on_trends_in_medical_affairs_607002Accessed April 24, 2018
   Google Scholar
• CianiOJommiCThe role of health technology assessment bodies in shaping drug developmentDrug Des Devel Ther2014822732281
   PubMed Web of Science ®Google Scholar
• PCCMedical Affairs Compliance: Analyze the Involvement of Medical Affairs in Commercial Activities2017 Available from: http://www.cbinet.com/sites/default/files/files/Connor_Brian_Pres.pdfAccessed April 26, 2018
   Google Scholar
• GrolRSuccesses and failures in the implementation of evidence-based guidelines for clinical practiceMed Care2001398 Suppl 24654
   Web of Science ®Google Scholar
• CochraneLJOlsonCAMurraySDupuisMToomanTHayesSGaps between knowing and doing: understanding and assessing the barriers to optimal health careJ Contin Educ Health Prof20072729410217576625
   PubMed Web of Science ®Google Scholar
• BuchanHGaps between best evidence and practice: causes for concernMed J Aust20041806 SupplS4815012579
   PubMed Web of Science ®Google Scholar
• McglynnEAAschSMAdamsJThe quality of health care delivered to adults in the United StatesN Engl J Med2003348262635264512826639
   PubMed Web of Science ®Google Scholar
• SaslowDSolomonDLawsonHWAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCA Cancer J Clin201262314717222422631
   PubMed Web of Science ®Google Scholar
• KomajdaMLapuertaPHermansNAdherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER surveyEur Heart J200526161653165915827061
   PubMed Web of Science ®Google Scholar
• McculloughMLPatelAVKushiLHFollowing cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortalityCancer Epidemiol Biomarkers Prev20112061089109721467238
   PubMed Web of Science ®Google Scholar
• ShapiroDWLaskerRDBindmanABLeePRContaining costs while improving quality of care: the role of profiling and practice guidelinesAnnu Rev Public Health1993142192418323588
   PubMed Web of Science ®Google Scholar
• SetiaSSubramaniamKTayJCTeoBWHypertension and blood pressure variability management practices among physicians in Sin-gaporeVasc Health Risk Manag20171327528528761353
   PubMed Web of Science ®Google Scholar
• SetiaSSubramaniamKTeoBWTayJCAmbulatory and home blood pressure monitoring: gaps between clinical guidelines and clinical practice in SingaporeInt J Gen Med20171018919728721085
   PubMed Web of Science ®Google Scholar
• SetiaSFungSSWatersDDDoctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of ath-erosclerotic cardiovascular disease in SingaporeVasc Health Risk Manag20151130331026082642
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical StudiesEvidence-Practice Gaps Report Volume 22005 Available from: https://www.nhmrc.gov.au/guidelines-publications/nic47Accessed April 25 2018
   Google Scholar
• GweeKAGohVLimaGSetiaSCoprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefitsJ Pain Res20181136137429491719
   PubMed Web of Science ®Google Scholar
• LansbergPLeeALeeZVSubramaniamKSetiaSNonadherence to statins: individualized intervention strategies outside the pill boxVasc Health Risk Manag2018149110229872306
   PubMed Web of Science ®Google Scholar
• ChadachanVMYeMTTayJCSubramaniamKSetiaSUnderstanding short-term blood-pressure-variability phenotypes: from concept to clinical practiceInt J Gen Med20181124125429950885
   PubMed Web of Science ®Google Scholar
• ShekellePEcclesMPGrimshawJMWoolfSHWhen should clinical guidelines be updated?BMJ2001323730515515711463690
   PubMed Web of Science ®Google Scholar
• JoshiCConsensus Guidelines: A Tool for Establishing Evidence-Based Practices2017 Available from: https://www.sciformix.com/medical-affairs-blog/consensus-guidelines-tool-establishing-evidence-based-practice/Accessed April 25, 2018
   Google Scholar
• Council of EuropeDeveloping a Methodology for Drawing Up Guidelines on Best Medical Practices2001 Available from: https://www.leitlinien.de/mdb/edocs/pdf/literatur/coe-rec-2001-13.pdfAccessed April 25, 2018
   Google Scholar
• Marie-OdileFMedical affairs writing: a key role to relay medical information to everyoneMedical Writing201625268
   Google Scholar
• JohansenMThomsenSFGuidelines for reporting medical research: a critical appraisalInt Sch Res Notices20161346026
   Google Scholar
• VarettoTCostaDCContinuing Medical Education Committee and UEMS-EACCMEEur J Nucl Med Mol Imaging201340347047423287995
   PubMed Web of Science ®Google Scholar
• World Health Organization (SEAR)Regional Guidelines for Continuing Medical Education (CME)/Continuing Professional Development (CPD) Activities2010 Available from: http://apps.searo.who.int/PDS_DOCS/B4489.pdfAccessed April 25, 2018
   Google Scholar
• MurgatroydGBContinuing Professional Development: The International Perspective2011 Available from: http://www.gmc-uk.org/CPD___The_International_Perspective_Jul_11.pdf_44810902.pdfAccessed April 25, 2018
   Google Scholar
• McleodPJMcleodAHIf formal CME is ineffective, why do physicians still participate?Med Teach200426218418615203529
   PubMed Web of Science ®Google Scholar
• DelsignoreJLCurrent guidelines regarding industry-sponsored continuing medical educationClin Orthop Relat Res20034124122127
   Web of Science ®Google Scholar
• VenkataramanRRanganathanLPonnishASAbrahamBKRamakrishnanNFunding sources for continuing medical education: An observational studyIndian J Crit Care Med201418851351725136190
   PubMedGoogle Scholar
• SteinbrookRFinancial support of continuing medical educationJAMA200829991060106218319417
   PubMed Web of Science ®Google Scholar
• ACCMEAnnual Report DataAccreditation Council for Continuing Medical Education2006 Available from: http://www.accme.org/sites/default/files/null/395_2006_Annual_report_2006_20070706.pdfAccessed April 26, 2018
   Google Scholar
• ACCMEACCME Data Report: Growth and Evolution in Continuing Medical Education2016 Available from: http://www.accme.org/news-releases/accme-data-report-shows-growth-and-evolution-accredited-continuing-medical-educationAccessed April 25, 2018
   Google Scholar
• WietingMWMevisHZuckermanJDThe role of industry in Internet educationClin Orthop Relat Res20034124122832
   Web of Science ®Google Scholar
• WilsonFSContinuing medical education: ethical collaboration between sponsor and industryClin Orthop Relat Res20034124123337
   Google Scholar
• HolmerAFIndustry strongly supports continuing medical educationJAMA2001285152012201411308442
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human ServicesFinal Guidance on Industry-Supported Scientific and Educational ActivitiesFood and Drug Administration1997 Available from: https://www.gpo.gov/fdsys/pkg/FR-1997-12-03/pdf/97-31741.pdfAccessed April 26, 2018
   Google Scholar
• MehtaPNDrugmakers and continuing medical educationIndian Pediatr200037662663010869142
   PubMedGoogle Scholar
• American College of Emergency PhysiciansGrants and Sponsorships2016 Available from: https://www.acep.org/Content.aspx?id=42670#sm.0001nd5f2nup5ebxuh32804wind6bAccessed April 25, 2018
   Google Scholar
• PfizerTransparency in Grants2018 Available from: https://www.pfizer.com/purpose/medical-grants/grant-transparencyAccessed April 25, 2018
   Google Scholar
• Celgene CorporationGrant Application Requirements2018 Available from: http://www.celgene.com/research-development/celgene-medical-affairs/educational-grant-requests/grant-application-requirements/Accessed April 25, 2018
   Google Scholar
• Boehringer Ingelheim GmbHApplying for an Independent Medical Education Grant2018 Available from: https://www.boehringer-ingelheim.us/funding-opportunities/medical-education-grants/applying-grantAccessed April 25, 2018
   Google Scholar
• PfizerDescriptions of Funding Types and Recipient Organizations2018 Available from: https://www.pfizer.com/responsibility/grants_contributions/description_funding_recipient_organizationsAccessed April 25, 2018
   Google Scholar
• Mallinckrodt PharmaceuticalsIndependent Medical Education Grants Available from: http://www.mallinckrodt.com/research/medical_affairs/independent_medical_educationAccessed April 25, 2018
   Google Scholar
• Janssen Scientific AffairsRequirements for Grants Requests2018 Available from: https://www.janssenime.com/requirements-for-grant-requestsAccessed April 25, 2018
   Google Scholar
• PfizerOrganizations Eligible to Apply Directly for Grants and Types of Initiatives Supported2018 Available from: http://www.pfizer.com/files/IGLC_OrganizationEligibility_effJuly2015.pdfAccessed April 25, 2018
   Google Scholar
• Boston Scientific CorporationIndependent Medical Education Program Grants2018 Available from: http://www.bostonscientific.com/en-US/corporate-citizenship/giving/grants-donations/request-types/educational-conference.htmlAccessed April 25, 2018
   Google Scholar
• BoardESCThe future of continuing medical education: the roles of medical professional societies and the health care industry: position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, Endorsed by the Board of the European Society of CardiologyEur Heart J2018
   Web of Science ®Google Scholar
• MorrisLTaitsmanJKThe agenda for continuing medical education: limiting industry’s influenceN Engl J Med2009361252478248220018969
   PubMed Web of Science ®Google Scholar
• RothmanDJMcdonaldWJBerkowitzCDProfessional medical associations and their relationships with industry: a proposal for controlling conflict of interestJAMA2009301131367137219336712
   PubMed Web of Science ®Google Scholar
• BrennanTARothmanDJBlankLHealth industry practices that create conflicts of interest: a policy proposal for academic medical centersJAMA2006295442943316434633
   PubMed Web of Science ®Google Scholar
• PracticesBContinuing Medical Education: Trends in Structure and Functional Management2018 Available from: https://www.best-in-class.com/bestp/domrep.nsf/products/continuing-medical-education-trends-in-structure-and-functional-management?opendocumentAccessed April 25, 2018
   Google Scholar
• HesseBWNelsonDEKrepsGLTrust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends SurveyArch Intern Med2005165222618262416344419
   PubMed Web of Science ®Google Scholar
• EysenbachGKohlerCWhat is the prevalence of health-related searches on the World Wide Web? Qualitative and quantitative analysis of search engine queries on the InternetAMIA Annu Symp Proc20032003225229
   Google Scholar
• FoxSDugganMHealth Online2013 Available from: http://www.pewinternet.org/2013/01/15/health-online-2013/Accessed April 25, 2018
   Google Scholar
• ClineRJHaynesKMConsumer health information seeking on the Internet: the state of the artHealth Educ Res200116667169211780707
   PubMed Web of Science ®Google Scholar
• DoupiPvan der LeiJRx medication information for the public and the WWW: quality issuesMed Inform Internet Med199924317117910654811
   PubMedGoogle Scholar
• LattheMLatthePMCharltonRQuality of information on emergency contraception on the InternetBr J Fam Plann2000261394310781966
   PubMedGoogle Scholar
• Directorate-General for Health and Food SafetyInformation to Patients: Legislative Approach2018 Available from: https://ec.europa.eu/health/human-use/information-to-patient/legislative_enAccessed April 25, 2018
   Google Scholar
• Pfizer Medicine Safety Education2018 Available from: https://www.pfizer.com/products/patient-safetyAccessed April 25, 2018
   Google Scholar
• DaviesNPublic-Private Partnerships Essential for Public Health Education2015 Available from: https://social.eyeforpharma.com/market-access/public-private-partnerships-essential-public-health-educationAccessed April 25 2018
   Google Scholar
• DonohueJMCevascoMRosenthalMBA decade of direct-to-consumer advertising of prescription drugsN Engl J Med2007357767368117699817
   PubMed Web of Science ®Google Scholar
• VentolaCLDirect-to-consumer pharmaceutical advertising. Therapeutic or toxic?P T2011361066968422346300
   PubMedGoogle Scholar
• ChengKWChongDWKDirect-to-consumer advertising in Hong Kong: possible impact and regulationHong Kong Pharma J2014214130136
   Google Scholar
• US Food and Drug AdministrationCFR - Code of Federal Regulations Title 21 Code of Federal Regulations2018 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=202.1Accessed April 25, 2018
   Google Scholar
• ParekhAMarcusRRobertsMRaischDWRisks and benefits of direct to consumer advertising on patient - provider relationshipsReport of the ISPOR Direct to Consumer Advertisements Working Group Available from: https://www.ispor.org/news/articles/June12/Risks-and-Benefits-of-Direct-To-Consumer.aspAccessed April 25, 2018
   Google Scholar
• GrazianoLDirect to Consumer Drug Advertisements: A Dangerous Game of Pitching Products to ParentsWright State University2009 Available from: https://corescholar.libraries.wright.edu/oamh_presentations/4/Accessed April 26, 2018
   Google Scholar
• World Health OrganizationDirect-to-consumer advertising under fireBull World Health Organ2009878565644
   Web of Science ®Google Scholar
• HollonMFDirect-to-consumer advertising: a haphazard approach to health promotionJAMA2005293162030203315855439
   PubMed Web of Science ®Google Scholar
• BaggottRForsterRHealth consumer and patients’ organizations in Europe: towards a comparative analysisHealth Expect2008111859418275405
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationCDER Patient-Focused Drug Development2018 Available from: https://www.fda.gov/Drugs/Devel-opmentApprovalProcess/ucm579400.htmAccessed April 26, 2018
   Google Scholar
• RachulCToewsMCaulfieldTControversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug”J Cyst Fibros201615562462927150823
   PubMed Web of Science ®Google Scholar
• MuthCCConflict of interest in medicineJAMA201731717181228464142
   PubMed Web of Science ®Google Scholar
• MyshkoDThe Medical Affairs-Marketing Connection2004 Available from: http://www.pharmavoice.com/article/137/Accessed August 1, 2018
   Google Scholar
• GoldacreBEvil ways of the drug companiesBad Science2007 Available from: https://www.theguardian.com/science/2007/aug/04/sciencenewsAccessed August 1, 2018
   Google Scholar
• FrancerJIzquierdoJZMusicTEthical pharmaceutical promotion and communications worldwide: codes and regulationsPhilos Ethics Humanit Med201491724679064
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyAbout Us2018 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/document_listing/document_listing_000426.jsp&midAccessed April 26 2018
   Google Scholar
• European UnionRegulations, Directives and Other Acts2018 Available from: https://europa.eu/european-union/eu-law/legal-acts_enAccessed April 26, 2018
   Google Scholar
• Australian Government Department of HealthTherapeutic goods advertising codeTherapeutic Goods Administration2018 Available from: https://www.tga.gov.au/publication/therapeutic-goods-advertising-codeAccessed April 26, 2018
   Google Scholar
• SecuritiesUSCommissionExchangeForeign Corrupt Practices Act2018 Available from: https://www.sec.gov/spotlight/foreign-corrupt-practices-act.shtmlAccessed April 26, 2018
   Google Scholar
• Transparency International UKThe Bribery Act2018 Available from: http://www.transparency.org.uk/our-work/business-integrity/bribery-act/#.WuFuxIhubIVAccessed April 26, 2018
   Google Scholar
• International Federation of Pharmaceutical Manufacturers & AssociationsOur Membership2018 Available from: https://www.ifpma.org/who-we-are/our-membership/full-members/companies/#!/Accessed April 26, 2018
   Google Scholar
• International Federation of Pharmaceutical Manufacturers & AssociationsCorporate Brochure: Committed to a Healthier FutureGeneva2016 Available from: https://www.ifpma.org/resource-centre/ifpma-corporate-brochure/Accessed April 26, 2018
   Google Scholar
• International Federation of Pharmaceutical Manufacturers & AssociationsGlobal Code Comparison: A Snapshot of IFPMA Member Associations’ Self-Regulation MechanismsInternational Federation of Pharmaceutical Manufacturers & Associations2018 Available from: https://www.ifpma.org/wp-content/uploads/2018/02/IFPMA_GCC_V7.pdfAccessed April 26, 2018
   Google Scholar
• International Federation of Pharmaceutical Manufacturers & AssociationsIFPMA Code of Practice2012 Available from: https://www.lif.se/globalassets/etik/dokument/ifpma_code_of_practice_2012.pdfAccessed April 26, 2018
   Google Scholar
• PfizerSales and Marketing Compliance2018 Available from: Pfizer. Sales and Marketing ComplianceAccessed April 26, 2018
   Google Scholar
• Takeda Pharmaceutical Company LimitedTakeda Global Code of Conduct2017 Available from: https://www.takeda.com/siteassets/system/who-we-are/corporate-governance/compliance/global-code-of-conduct_en.pdfAccessed April 26, 2018
   Google Scholar
• Astellas Pharma IncPolicies & Position Statements2018 Available from: https://www.astellas.com/en/about/policies-and-position-statementsAccessed April 26, 2018
   Google Scholar
• AstraZenecaAstraZeneca Global Policy Communications2015 Available from: https://www.astrazeneca.com/content/dam/az/PDF/Global-Communications%20Policy_v6.0_December_2015.pdfAccessed April 26, 2018
   Google Scholar
• GlaxoSmithKline plcOur Code of Practice for Promotion of Prescription Medicines and for Scientific Engagement2018 Available from: https://www.gsk.com/media/2831/code-of-practice.pdfAccessed April 26, 2018
   Google Scholar
• WerlingKCarnellHMcCormickDFocus on Life Science Compliance: The Evolution of Medical Affairs Departments2011 Available from: https://www.mcguirewoods.com/news-resources/publications/health_care/focus-life-science-compliance-nov-2011.pdfAccessed August 1, 2018
   Google Scholar
• British Medical AssociationThe Pharmaceutical Physician2013 Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwiVm43n6J3aAhVCso8KHSLxBYEQFggsMAA&url=https%3A%2F%2Fwww.bma.org.uk%2F-%2Fmedia%2Ffiles%2Fpdfs%2Fabout%2520the%2520bma%2Fhow%2520we%2520work%2Fmedical%2520academics%2Fpharmaceuticalphysican_sept2013_update.pdf&usg=AOvVaw0pemmjh2E-xGyAz54SO7ZfAccessed April 26, 2018
   Google Scholar
• C.E.L. for PharmaMedical Affairs Training Courses2018 Available from: https://www.celforpharma.com/medical-affairs-training-coursesAccessed April 26, 2018
   Google Scholar
• Duke NUS Medical SchoolJoint Alliance Duke-NUS Education Certificate Programme in Medical Affairs Available from: https://www.duke-nus.edu.sg/core/page/jade-certification-programme-medical-affairs-brochureAccessed April 26, 2018
   Google Scholar
• IFAPP AcademyThe IFAPP-Kings College Medical Affairs in Medicines Development Certification Timelines2018 Available from: https://ifappacademy.org/index.php/timelines/Accessed April 26, 2018
   Google Scholar
• IFAPP AcademyIFAPP Academy2018 Available from: https://ifap-pacademy.org/Accessed April 26, 2018
   Google Scholar
• IFAPP AcademyIFAPP Academy Student Requirements2018 Available from: https://ifappacademy.org/index.php/ifapp-academy-student-requirements/Accessed April 26, 2018
   Google Scholar
• International Committee of Medical Journal EditorsRecommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals2017 Available from: http://www.icmje.org/icmje-recommendations.pdfAccessed April 25, 2018
   Google Scholar
• BattistiWPWagerEBaltzerLGood publication practice for communicating company: sponsored medical research: GPP3Ann Intern Med2015163646146426259067
   PubMed Web of Science ®Google Scholar
• CONSORTConsolidated Standards of Reporting Trials Available from: http://www.consort-statement.orgAccessed April 26, 2018
   Google Scholar
• von ElmEAltmanDGEggerMStrengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ2007335762480680817947786
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
   PubMed Web of Science ®Google Scholar
• StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
   PubMed Web of Science ®Google Scholar
• Des JarlaisDCLylesCCrepazNTREND GroupImproving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statementAm J Public Health200494336136614998794
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationWhat We Do2018 Available from: https://www.fda.gov/AboutFDA/WhatWeDo/default.htmAccessed April 26, 2018
   Google Scholar
• UK GovernmentServices and informationMedicines and Health-care products Regulatory Agency Available from: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency/services-informationAccessed April 26, 2018
   Google Scholar
• Government of CanadaHealth Canada Available from: https://www.canada.ca/en/health-canada.htmlAccessed April 26, 2018
   Google Scholar
• Health Sciences AuthorityCorporate Profile2018 Available from: http://www.hsa.gov.sg/content/hsa/en/About_HSA/Corporate_Profile.htmlAccessed April 26, 2018
   Google Scholar
• New Zealand Medicines and Medical Devices Safety AuthorityAbout Medsafe Available from: http://www.medsafe.govt.nz/other/about.aspAccessed April 26, 2018
   Google Scholar
• Japan Pharmaceutical Manufacturers AssociationRegulatory Information Task Force: Information on Japanese Regulatory AffairsPharmaceutical Administration and Regulations in Japan2017 Available from: http://www.jpma.or.jp/english/parj/pdf/2017_contents.pdfAccessed April 26, 2018
   Google Scholar
• Central Drugs and Standard Control OrganizationAbout Us Available from: http://www.cdsco.nic.in/forms/contentpage1.aspx?lid=962Accessed April 26, 2018
   Google Scholar
• China Food and Drug AdministrationMain Responsibilities Available from: http://eng.sfda.gov.cn/WS03/CL0756/Accessed April 26, 2018
   Google Scholar
• RothsteinNAProtecting privacy and enabling pharmaceutical sales on the Internet: a comparative analysis of the United States and CanadaFed Commun Law J2001532 Article 6
   Google Scholar
• UK Government LegislationThe Medicines (Advertising) Regulations1994 Available from: https://www.legislation.gov.uk/uksi/1994/1932/contents/madeAccessed April 26, 2018
   Google Scholar
• European Commission Health and Food Safety Directorate-GeneralProcedures for Marketing Authorisation2018 Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-2/vol2a_chap1_rev7_201712.pdfAccessed July 2, 2018
   Google Scholar
• Singapore Statutes OnlineHealth Products Act2008 Available from: https://sso.agc.gov.sg/Act/HPA2007Accessed April 26, 2018
   Google Scholar
• Federal Register of LegistlationTherapeutic Goods Act1989 Available from: https://www.legislation.gov.au/Details/C2017C00226Accessed April 26, 2018
   Google Scholar
• Pharmaceutical Affairs LawJapan Available from: http://www.jouhoukoukai.com/repositories/source/pal.htmAccessed April 26, 2018
   Google Scholar
• International Comparative Legal Guides. Pharmaceutical Advertising2017Japan Available from: https://iclg.com/practice-areas/pharmaceutical-advertising/pharmaceutical-advertising-2017/japanAccessed April 26, 2018
   Google Scholar
• International Comparative Legal Guides. Pharmaceutical Advertising2017India Available from: https://iclg.com/practice-areas/pharmaceutical-advertising/pharmaceutical-advertising-2017/indiaAccessed April 26, 2018
   Google Scholar
• MaFLouNChinese regulation of off-label use of drugsFood Drug Law J201368218920024640468
   PubMed Web of Science ®Google Scholar
• China Food and Drug AdministrationProvisions for Drug Advertisement Examination2007 Available from: http://eng.sfda.gov.cn/WS03/CL0768/61649.htmlAccessed April 28, 2018
   Google Scholar
• Database of Laws and Regulations: National People’s CongressEconomic and Advertisement Law of the People’s Republic of China2018 Available from: http://www.npc.gov.cn/englishnpc/Law/2007-12/12/content_1383782.htmAccessed April 28, 2018
   Google Scholar